1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

---

In the present era, auto-immune diseases are becoming one of the highest diagnosed disease cases in the world and among all the auto-immune diseases, Lupus nephritis is considered to be responsible for taking the lives of millions of pat...

Read More

---

Combinational Therapy to Boost the Market Size of Melanoma Cancer Market

Release Date: 08 November 2020

Researchers are inclined towards adding plasmid IL-12 (pIL-12-EP) agent tavokinogene telseplasmid to pembrolizumab (Keytruda) in order to develop a deep systemic response in patients having progressive anti–PD-1–refractory ad...

Read More

---

Novel Oral Class of Drug More Beneficial than CAR-T Cell Therapy for DLBCL Patients

Release Date: 07 November 2020

There are number of cases where the patients suffering from diffused large B cell lymphoma have experienced refractory disease after receiving the treatment for it. But with the arrival of CAR-T cell therapy, the treatment option for the...

Read More

---

Inclination of the Researchers for Overcoming Osimertinib Resistance in NSCLC Patients

Release Date: 07 November 2020

For the treatment of the patients suffering from EGFR mutant non-small cell lung cancer, Osimertinib brand name Tagrisso has emerged as a frontline treatment option. The drug is believed to overcome the resistance challenge that is developed by the patients sufferin...

Read More

---

Quantitative Assay for Immune Checkpoints Impacting the Overall Immunotherapy Market

Release Date: 07 November 2020

Immunotherapy and more specifically immune checkpoint inhibitors have initiated and led to the development of completely novel treatment regimen shift in case of urothelial carcinoma. Researchers have now analyzed the therapeutic value o...

Read More

---

CTLA-4 Expression Linked With High Survival Rate by Checkpoint Inhibitor Therapy in Renal Cancer

Release Date: 07 November 2020

There are several molecules or proteins that are witnessed to improve the overall survival rate of the cancer patients. Among all, Cytotoxic T Lymphocyte associated Protein 4 is estimated to be one of the important protein molecules that...

Read More

---

Immune Checkpoint Inhibitors and TILs to Show Effectiveness against Angiosarcoma

Release Date: 07 November 2020

Angiosarcoma is believed to be one of the most aggressive types of skin cancers diagnosed mostly in older white people. As per extensive research conducted for the angiosarcoma it is estimated that the immune-therapies available for the ...

Read More

---

KRAS Gene Mutation Targeted by Researchers for Wide Variety of Cancers

Release Date: 06 November 2020

KRAS is a gene that has now become the novel target for an experimental vaccine as it is the gene that is involved in the overall development and progression of different types of cancers such as lung cancer, bowel cancer and pancreatic ...

Read More

---

Tri-Specific Antibodies Effective against HIV Strains in Monkeys

Release Date: 06 November 2020

Artificially developed antibodies have been found to be more prominent in protecting monkey from two strains of SHIV and a monkey form of HIV when compared with the natural antibody. The novel developed antibody in the lab is estimated t...

Read More

---

Super-Engineered Antibodies as Novel Emerging Therapy against HIV

Release Date: 06 November 2020

A group of researchers have researched about the HIV strains and found a vaccine that could attack 99% of the HIV strain infection in case of primates. The antibody developed by the researchers is estimated to be targeting some of the im...

Read More

---

ICMR Researchers Identify BCG as a Protection Shield Over the Spread of Covid-19

Release Date: 06 November 2020

As per the research conducted for the ongoing pandemic due to Covid-19, Bacillus Calmette-Guerin vaccine is estimated to provide primary protection against the Coronavirus in elderly people. After the clinical research study of BCG vacci...

Read More

---

Novel CAR-T Cell Therapy Studied for its Effectiveness in the Treatment of Prostate Cancer

Release Date: 05 November 2020

For the treatment of the patients suffering from metastatic castration-resistant prostate cancer (mCRPC), CART-PSMA-TGFandbeta;Rd as adoptive chimeric antigen receptor (CAR) T-cell therapy is estimated to be safe as well as feasible when...

Read More

---

Sertraline Showing Promising Anti-Tumor Activity in Cancer Patients

Release Date: 05 November 2020

As per research findings it is very clear that the growth of the cancer cells is largely dependent on the biological mechanisms. It has been found in case of different types of cancer cells that they produce ample amount of two amino aci...

Read More

---

Glioblastoma to Receive Novel Personalized Cancer Vaccine

Release Date: 05 November 2020

Personalized cancer vaccine is one of the most discussed therapeutics at global level. Hundreds of bio-pharmaceutical companies are now inclined towards development of the personalized cancer vaccine as the mortality rate due to cancer i...

Read More

---

Addition of Two Components to Activate More Immunogenic Response against Melanoma

Release Date: 05 November 2020

Introduction of two components are witnessed to increase the number and the effectiveness of the dendritic cells in case of skin cancer melanoma. A group of researchers from Tisch Cancer Institute at the Icahn School of Medicine and Nati...

Read More

---

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |